Exploring the Role of Umbilical Cord and Cord Blood in Regenerative Medicine

Umbilical cord (UC) and umbilical cord blood (UCB) have emerged as promising sources of stem cells for regenerative medicine, offering potential treatments for a wide range of chronic diseases due to their ability to differentiate into mature cells and activate endogenous progenitor cells. Mesenchymal Stem Cells (MSCs) derived from these sources are particularly notable for their immune-modulating capabilities and production of growth factors. UC and UCB stem cells are ethically acceptable, easily procured, and present no serious ethical challenges, making them attractive for clinical use. This review discusses the mechanistic pathways, translational challenges, and potential of UCB and UC as both standalone treatments and platforms for enhancing existing therapies. It also highlights preclinical and clinical results, emphasizing the need for future research to address regulatory challenges and optimize delivery systems to improve patient outcomes.